Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04280926 · ClinicalTrials.gov registry record
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction
A clinical trial, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT04280926: Completed study, sponsored by Hennepin Healthcare Research Institute.
NCT04280926 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04280926 has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
Primary Outcome
Adjudicated diagnosis of acute myocardial injury using the Abbott hs-cTnI assay
Interventions
- DIAGNOSTIC_TEST Cardiac Troponin Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2024-10-13 |
What the finished NCT04280926 record still lists
NCT04280926 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Troponin Testing is the first listed.
NCT04280926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04280926 about?
NCT04280926 is a clinical study titled "Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction". Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
What is the current status of trial NCT04280926?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2020-10-13. Estimated completion is 2024-10-13.
What interventions are being tested in trial NCT04280926?
The interventions under investigation include: Cardiac Troponin Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04280926?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI